AFME.PA
Affluent Medical SA [AFME.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AFME.PA Stock Summary
Top 10 Correlated Stocks
AFME.PA
In the News
AFME.PA Financial details
Company Rating
-
Market Cap
65.96M
Income
-22.52M
Revenue
1.22M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
52
Optionable
No
Shortable
Yes
Earnings
28 Sep 2023
P/E
-2.11
Forward P/E
-
PEG
-5.63
P/S
-
P/B
0.95
P/C
-
P/FCF
-4.68
Quick Ratio
0.3
Current Ratio
0.83
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.83
EPS next Y
-
EPS next Q
-
EPS this Y
1.25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
2.38%
Revenue last 5Y
98.91%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
90.86%
SMA50
130.52%
SMA100
132.03%
Inst Own
-
Inst Trans
-
ROA
-25%
ROE
-39%
ROC
-0.28%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.93-2.3
52W High
-
52W Low
-
RSI
73.92
Rel Volume
10.16
Avg Volume
10.9K
Volume
110.67K
Perf Week
7.11%
Perf Month
114.21%
Perf Quarter
154.38%
Perf Half Y
166.01%
-
-
-
-
Beta
0.501
-
-
Volatility
0.32%, 0.79%
Prev Close
13.06%
Price
4.07
Change
36.12%
Company Profile
- Volume Average 10.9K
- Market Capitalization 65.96M
- Employee 52
- CEO Sebastien Ladet Ph.D.
- Headquarters Aix-en-Provence,FR
- IPO Date 2021-06-14
-
Website
https://www.affluentmedical.com 
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
